ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,799Medicare Part D Prescriptions Filled, Including Refills

Rank: 292 out of 1107

$640K Total Retail Price of All Prescriptions

Rank: 265 out of 1107

271 Patients Receiving at Least One Drug in Part D
37%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

37% of this provider’s 271 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

25% of this provider’s 271 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

4% of this provider’s 4,202 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
LISINOPRIL 516 207 1 2
HYDROCODONE-ACETAMINOPHEN 445 225 S3 2 1
METFORMIN HCL 338 138 3 8
OXYCODONE-ACETAMINOPHEN 325 106 S2 4 104
AMLODIPINE BESYLATE 319 159 5 6
HYDROCHLOROTHIAZIDE 251 123 6 11
NEXIUM 240 50 7 18
OMEPRAZOLE 232 99 8 4
ATENOLOL 215 83 9 19
FUROSEMIDE 203 96 10 7
OXYCODONE HCL-ACETAMINOPHEN 199 47 S2 11 93
LEVOTHYROXINE SODIUM 191 67 12 3
SIMVASTATIN 190 69 13 5
OXYCODONE HCL 182 58 S2 14 100
AMITRIPTYLINE HCL 181 76 R 15 48
METHADONE HCL 181 24 S2 15 201
RANITIDINE HCL 160 63 17 21
PROAIR HFA 156 53 18 37
POTASSIUM CHLORIDE 131 65 19 14
IBUPROFEN 131 48 19 63
METOPROLOL TARTRATE 127 49 21 10
ATORVASTATIN CALCIUM 127 14 21 13
CRESTOR 108 69 23 23
CITALOPRAM HBR 107 54 24 17
TRAZODONE HCL 106 41 25 33
ALLOPURINOL 105 78 26 36
VENTOLIN HFA 103 60 27 97
GABAPENTIN 101 31 28 9
SPIRIVA 93 28 29 57
ENALAPRIL MALEATE 92 30 30 98
OXYCONTIN 80 13 S2 31 167
CHLORTHALIDONE 79 19 32 175
LOVASTATIN 77 12 33 55
BUPROPION HCL SR 76 15 34 190
LISINOPRIL-HYDROCHLOROTHIAZIDE 75 23 35 24
PROMETHAZINE HCL 74 0 R 36 44
JANUVIA 74 33 36 60
PAROXETINE HCL 74 33 36 45
SERTRALINE HCL 69 40 39 20
VERAPAMIL ER 68 41 40 113
ADVAIR DISKUS 67 18 41 54
GLIPIZIDE 66 33 42 64
ROPINIROLE HCL 63 24 43 69
CYCLOBENZAPRINE HCL 63 26 R 43 56
ZOLPIDEM TARTRATE 63 27 43 22
WARFARIN SODIUM 63 43 43 15
PRAVASTATIN SODIUM 62 35 47 12
SYMBICORT 61 0 48 124
TRICOR 60 27 49 95
ACTOS 57 17 50 132
BYSTOLIC 57 34 50 138
ESCITALOPRAM OXALATE 56 30 52 82
CLOPIDOGREL 55 22 53 28
CARVEDILOL 54 28 54 27
PLAVIX 54 15 54 39
LIPITOR 50 13 56 109
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 29, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.